- In 2021, about 8.4 million people globally had type 1 diabetes.
- There is currently no cure for type 1 diabetes and those with the condition have to provide their body with missing insulin for their entire life.
- The Food and Drug Administration (FDA) recently approved a new therapy for type 1 diabetes called Lantidra.
- Studies show after receiving Lantidra, some study participants did not need to administer insulin for more than 5 years.
As of 2021, about
Currently, there is no cure for type 1 diabetes. The main treatment for type 1 diabetes is providing missing insulin through injections or a pump.
Additionally, people with type 1 diabetes may be prescribed
In late June 2023, the Food and Drug Administration (FDA)
Two safety and efficacy studies found that 21 participants who took Lantidra did not need to administer themselves insulin for a year or more.
Twelve of those participants did not need to take insulin for up to 5 years, and 9 did not need insulin for over 5 years.
Lantidra was developed to assist people with type 1 diabetes who are unable to hit healthy blood sugar levels because of repeated episodes of low blood sugar, despite intensive diabetes management and education.
“A subset of patients with type 1 diabetes cannot control their blood sugars, despite [the] use of [the] best available insulin delivery technology and expert care,” Prof. Jose Oberholzer, ordinarius and chair of the Department of Visceral and Transplant Surgery at the University of Zurich, Switzerland, explained to Medical News Today.
Prof. Oberholzer was a lead…
Read the full article here